AzTrials
AzTrials

End Stage Renal Disease (ESRD)NCT07061028

Effect of PMR on Pain In Patients With ESRD

A study testing Progressive Muscle Relaxation in people with End Stage Renal Disease (ESRD), run by Jordan University of Science and Technology at 1 site in Jordan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Patients with chronic end-stage renal disease (ESRD) commonly experience chronic pain, which significantly impair their quality of life. This pain is often exacerbated by maladaptive cognitive appraisals, in particular pain catastrophizing. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
End Stage Renal Disease (ESRD)
What is being tested?
Progressive Muscle Relaxation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
1 siteJordan
Study dates
1 Feb 2024to 28 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patients with ESRD who had a smartphone
  • aged eighteen years or above
  • and received hemodialysis at least thrice a week

Who cannot join

  • The patients with ESRD patients who received psychotherapy
  • or took regular psychopharmacological and analgesic treatment

Trial locations and contacts

1 site in 1 country.

Jordan1 site
  • Jordan University of Science and Technology/ King Abdullah University Hospital

    Irbid, 22110

Other trials in Jordan

About this study

Official title: The Effects of Progressive Muscle Relaxation on Pain Intensity, Pain Catastrophizing, and Quality of Life in Patients With End Stage Renal Disease: A Randomized Controlled Study

Background: Patients with chronic end-stage renal disease (ESRD) commonly experience chronic pain, which significantly impair their quality of life. This pain is often exacerbated by maladaptive cognitive appraisals, in particular pain catastrophizing. This study investigated the effectiveness of progressive muscle relaxation (PMR) on pain intensity, pain catastrophizing, and health-related quality of life on patients undergoing with ESRD.

Methods: This randomized controlled parallel study was conducted in a governmental hospital in Jordan in 2024. Participants (N= 104) were randomly assigned to an experimental group offered five sessions of 30 minutes of PMR per week over a total period of five weeks and a control group, which receives standard treatment. The outcomes were measured by Arabic validated scales such as the Pain Catastrophizing Scale, Numerical Pain Rating Scale and the Renal Disease Quality of Life questionnaire at baseline and the end of the intervention.

Read the detailed description

Patients with chronic end-stage renal disease (ESRD) commonly experience chronic pain, which significantly impair their quality of life. This pain is often exacerbated by maladaptive cognitive appraisals, in particular pain catastrophizing. This study investigated the effectiveness of progressive muscle relaxation (PMR) on pain intensity, pain catastrophizing, and health-related quality of life on patients undergoing with ESRD.

This study using a pretest-post-test randomized controlled parallel design was conducted in a Dialysis facility in a Government Military Hospitals. This facility is the biggest in the middle east that includes 58 dialysis machines and treats 2,200-2,240 patients monthly. The participants were chosen by a convenience sampling method and then randomly allocated into experimental and control groups. Research assistant who did not participate in any phase of the study (e.g. recruitment or measurement) performed the participants' allocation using a cluster random assignment method explained below.

The sample size was calculated using G*power 3.1.9.4. The estimated sample size was 102 given an independent t-test, a medium effect size of 0.5, an alpha of 0.05, and a power of 0.8. Considering a 15% attrition rate, 117 participants are needed for the sample. The final necessary sample size was 120 individuals after 3 persons were added to be more cautious. Out of the 170 individuals that had their eligibility evaluated, 120 were found to be eligible and consented to take part. 104 of them finished the study, and their data was analysed. Due to health concerns, the remaining 16 participants decided to leave the study prior to the collection of baseline data.

After getting the approval of the Institutional Research Board (IRB), the research investigator approached hospital management requesting them to allow the study to be carried out at their hospital. Upon consent, the researcher interviewed the subjects individually on their study objectives and processes. The informed consent statement was forwarded to all the participants who had agreed to participate in the research. The participants were then randomly assigned to the experimental group and the control group using a cluster random assignment to avoid contamination. To implement this assignment approach, a list of participants who met the criteria for the research was made, along with their shifts (A, B, and C). Participants received hemodialysis three times a week on either Sunday, Tuesday, and Thursday (STT) or Monday, Wednesday, and Saturday (MWS). The above arrangement resulted in six clusters: two shifts per week (STT or MWS) × three shifts per day (A, B, and C). The clusters (STT Shift A, 2) STT Shift B, 3) STT Shift C, 4) MWS Shift A, 5) MWS Shift B, and 6) MMWS Shift C were defined by a mixture of hemodialysis days and shifts. Listing all six clusters-each with twenty subjects according to the sample size calculation-was an initial procedure. Following that, these clusters were randomly assigned to the control or experimental groups. Randomizing participants was carried out using a random number generation technique to ensure an unbiased assignment. This random assignment method was used by an investigator who had no involvement in recruiting participants and was blind to the participant list.

After randomization, baseline assessments of the study sociodemographics and dependent variables were conducted in the hemodialysis unit before the intervention started. At the end of the intervention, which occurred five weeks following the actual MBI training, the study dependent variables were assessed again. A qualified research assistant collected the data without taking part in other study components. A qualified research assistant collected the data without taking part in other study components. This research assistant has a strong background in nephrology and is a registered nurse. Every measurement in the hemodialysis unit was conducted in private, with similar settings (e.g., temperature) and conditions (e.g., sitting position). There was nobody there when they finished the questionnaire.

This study employed five weekly 30-minute sessions of Progressive Muscle Relaxation (PMR) based on the ABC relaxation theory. The PMR intervention involve tense-and-release exercises for 11 different muscle groups, including hands, arms, sides, back, shoulders, face, neck, stomach, chest, legs, and feet. For five to ten seconds, each muscle group is contracted, and for twenty to thirty seconds, it is relaxed. The sensations of stress and relaxation were the participants' main concern. To release any residual tension, they looked at each muscle group after the workout. With the exception of the time needed for measurements and instructions, the entire operation took roughly thirty minutes.

Participants in the experimental group attended three weekly PMR sessions during their five weeks of hemodialysis. In order to allow participants to practice the PMR procedure during hemodialysis sessions, it was recorded on audio. These recordings were provided to them via email or WhatsApp, depending on their option. This audio recording was made utilizing Smith's protocol by a certified study researcher who holds a higher degree in nursing and has extensive experience practicing and delivering mind-body therapies. The audio recording was confirmed and authenticated by two psychologists with strong PMR backgrounds. The researcher managed any interruptions, kept the PMR delivery under control, protected confidentiality, and made sure they could practice efficiently. Although it was not required, participants were encouraged to practice the PMR at home during the five-week trial period. Prior to the trial, participants in both groups were told to stick to their regular schedules and refrain from pursuing alternative or psychiatric therapy to elevate their mood. They were also requested to inform the researcher if they decided to seek such treatments during the study time. They were also requested to notify the researcher if they used analgesics during the study period.

Before the intervention started, a face-to-face instructional session was held to help participants better understand it. Consequently, the participants in the experimental group attended an additional 2-hour education session during which the researcher gave them thorough information regarding the purpose and approach of the intervention. During the workshop, participants learnt the basics of the PMR program and were given a detailed walkthrough of the full intervention process. Participants were encouraged to ask questions and take part in conversations to ensure they understood the intervention. The control group received no interaction from the researcher. However, following the conclusion of the investigation, the control group participants were given the audio recordings of the intervention protocol along with an explanation of them.

Version 25 of the statistical package for social science was used to analyze our data. To provide an overview of the study results, descriptive statistics were applied. Because the data was not normally distributed, we described categorical variables with frequency and percentage and continuous variables with median and IQR. Histogram, the Shapiro-Wilk test, and skewness and kurtosis indices were used to examine the normality across groups. The homogeneity of variance was examined using Levene's test. If continuous variables' data did not follow the normal distribution and had unequal variances, non-parametric tests such as Mann-Whitney U tests and Wilcoxon Signed Ranks Test replaced parametric tests including independent tests and dependet t-tests respectively.

A chi-square test was performed to study whether there were baseline differences on sociodemographic categorical variables between the study groups. Mann-Whitney U tests were used to compare the difference between two independent groups at baseline and after the intervention as normality and/or homogeneity of variance were violated. To find out if the mean scores improved within the study groups, a Wilcoxon Signed Ranks Test was run, since not all data followed a normal distribution.

This study obtained a approval by the IRB at Jordan University of Science and Technology. The consenting participants were made to read and sign a consent form after which they were allowed to engage in the study. They were assured that they would not face any impact on their access to care in case they refuse to participate. The participants were informed that their names were converted to numbers because of their anonymity and that the research information would be stored safely in an encrypted file cabinet which can only be accessed by the investigators. No eligible patient was excluded due to her or his racio- ethnic background. The intervention was stopped, and the doctor was notified right away if the participants experienced discomfort.

Being tested
Progressive Muscle Relaxation, Control Group
Keywords
Progressive Muscle Relaxation, End Stage Kidney Disease, Pain, Pain Catastrophizing, Quality of Life
Medical subject headings
Kidney Failure, Chronic, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Progressive Muscle RelaxationBehavioural

    This intervention involves five weekly 30-minute sessions of Progressive Muscle Relaxation (PMR) based on the ABC relaxation theory. The PMR protocol developed by Smith (2005) involve tense-and-release exercises for 11 different muscle groups, including hands, arms, sides, back, shoulders, face, neck, stomach, chest, legs, and feet. For five to ten seconds, each muscle group is contracted, and for twenty to thirty seconds, it is relaxed. The sensations of stress and relaxation were the participants' main concern. To release any residual tension, they looked at each muscle group after the workout. With the exception of the time needed for measurements and instructions, the entire operation took roughly thirty minutes.

  • Control GroupOther

    The control group received no intervention from the researcher during the study. However, following the intervention, the control group participants were given the audio recordings of the intervention protocol along with an explanation of them.

Study groups in NCT07061028
Study groupRoleWhat they receive
Progressive Muscle RelaxationExperimentalThis group received five weekly 30-minute sessions of Progressive Muscle Relaxation (PMR) based on the ABC relaxation theory. The PMR protocol developed by Smith (2005) involve tense-and-release exercises for 11 different muscle groups, including hands, arms, sides, back, shoulders, face, neck, stomach, chest, legs, and feet. For five to ten seconds, each muscle group is contracted, and for twenty to thirty seconds, it is relaxed. The sensations of stress and relaxation were the participants' main concern. To release any residual tension, they looked at each muscle group after the workout. With the exception of the time needed for measurements and instructions, the entire operation took roughly thirty minutes.
Receives: Behavioral: Progressive Muscle Relaxation
Waitlist Control GroupOtherThe control group received no intervention from the researcher during the study. However, following the intervention, the control group participants were given the audio recordings of the intervention protocol along with an explanation of them.
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Arabic Pain Catastrophizing Scale

    The Arabic Pain Catastrophizing Scale (PCS) was used to measure pain catastrophizing in the study. It consists of 13 items that evaluate an individual's thoughts and emotions connected to pain. Three aspects of pain catastrophizing are measured by PCS: helplessness (6 items) magnification (3 items) and rumination (4 items). Patients rate how often they experience the above thoughts and sensations when they are in pain. They use a 5-point Likert-type scale, ranging from 0 (not at all) 1 to 4 (all the time). By adding together, the scores for each question, one may get the subscale scores. These scores are between 0 to 52, with higher scores are indicative of a greater pain catastrophizing. A reliable and valid method for assessing catastrophizing in chronic pain patients who speak Arabic is the Arabic version of the Pain Catastrophizing Scale (PCS). The scale demonstrated strong internal consistency, with a Cronbach's α of 0.94.

    Measured: From enrollment to the end of treatment at 6 weeks

  2. Visual Analog Scale (VAS)

    The scale asks respondents to select the value (between 0 and 10) which most closely represents their level of pain. High test-retest reliability has been demonstrated by both literate and illiterate rheumatoid arthritis patients (r = 0.96 and 0.95, respectively). With correlation ranging from 0.86 to 0.95, the NPRS was found to have a strong association with the VAS for construct validity among individuals with chronic pain disorders (pain that lasts a minimum of six months). The scale has been found to be a valid and reliable tool for assessing pain severity in Arabic-speaking nations.

    Measured: From enrollment to the end of intervention at 6 weeks

  3. Arabic version of the kidney disease-related Quality of Life questionnaire

    Quality of life was assessed using the Arabic version of the kidney disease-related Quality of Life questionnaire (KDQOL-36). It comprises four subscales: generic core [Physical Component Summary (PCS, 12 items) and mental component summary (MCS, 12 items); symptoms and issues (12 items); burden of renal disease (4 items); and impacts of kidney disease (8 items) (Elamin et al., 2019). The raw, pre-coded numerical values of each item are linearly transformed into a scale ranging from 0 to 100, where higher numbers denote a higher quality of life. Positive psychometric characteristics were found in Arabic patients with chronic renal insufficiency using the scale's Arabic version. With a Cronbach's alpha of 0.81, the KDQOL-36 translation demonstrated high internal reliability.

    Measured: From enrollment to the end of intervention at 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2025
  2. Study start1 Feb 2024
  3. Primary completion28 May 2024
  4. Study completion28 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07061028
Sponsor's protocol ID
2024/136
Status last verified
Jul 2025
First submitted
2 Jul 2025
Last updated
11 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Smith, J. C. (2005). Relaxation, meditation, & mindfulness: A mental health practitioner's guide to new and traditional approaches. Springer Publishing Company.

  • Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995). The Pain Catastrophizing Scale: Development and validation. Psychological Assessment, 7(4), 524-532. https://doi.org/10.1037/1040-3590.7.4.524

  • Terkawi AS, Sullivan M, Abolkhair A, Al-Zhahrani T, Terkawi RS, Alasfar EM, Khait SSA, Elkabbani A, Kabbani N, Altirkawi KA, Tsang S. Development and validation of Arabic version of the pain catastrophizing scale. Saudi J Anaesth. 2017 May;11(Suppl 1):S63-S70. doi: 10.4103/sja.SJA_130_17.

    PubMed 28616005
  • Zhang C, Zhang Z, Li Y, Feng C, Meng H, Gao Y, Lo WLA, Wang C. Pain Catastrophizing Is Related to Static Postural Control Impairment in Patients with Nonspecific Chronic Low Back Pain: A Cross-Sectional Study. Pain Res Manag. 2020 Oct 28;2020:9629526. doi: 10.1155/2020/9629526. eCollection 2020.

    PubMed 33193926
  • Wolff B, Burns JW, Quartana PJ, Lofland K, Bruehl S, Chung OY. Pain catastrophizing, physiological indexes, and chronic pain severity: tests of mediation and moderation models. J Behav Med. 2008 Apr;31(2):105-14. doi: 10.1007/s10865-007-9138-z.

    PubMed 18158618
  • Kesik G, Ozdemir L, Mungan Ozturk S. The Effects of Relaxation Techniques on Pain, Fatigue, and Kinesiophobia in Multiple Sclerosis Patients: A 3-Arm Randomized Trial. J Neurosci Nurs. 2022 Apr 1;54(2):86-91. doi: 10.1097/JNN.0000000000000620.

    PubMed 35149625
  • Kazak A, Ozkaraman A. The Effect of Progressive Muscle Relaxation Exercises on Pain on Patients with Sickle Cell Disease: Randomized Controlled Study. Pain Manag Nurs. 2021 Apr;22(2):177-183. doi: 10.1016/j.pmn.2020.02.069. Epub 2020 Mar 26.

    PubMed 32224022
  • Karakus A, Uzelpasaci E, Akyurek G. The comparative effectiveness of progressive relaxation training on pain characteristics, attack frequency, activity self-efficacy, and pain-related disability in women with episodic tension-type headache and migraine. PLoS One. 2025 Apr 28;20(4):e0320575. doi: 10.1371/journal.pone.0320575. eCollection 2025.

    PubMed 40293994
  • Kaplan Serin E, Ovayolu N, Ovayolu O. The Effect of Progressive Relaxation Exercises on Pain, Fatigue, and Quality of Life in Dialysis Patients. Holist Nurs Pract. 2020 Mar/Apr;34(2):121-128. doi: 10.1097/HNP.0000000000000347.

    PubMed 31567304
  • Izgu N, Gok Metin Z, Karadas C, Ozdemir L, Metinarikan N, Corapcioglu D. Progressive Muscle Relaxation and Mindfulness Meditation on Neuropathic Pain, Fatigue, and Quality of Life in Patients With Type 2 Diabetes: A Randomized Clinical Trial. J Nurs Scholarsh. 2020 Sep;52(5):476-487. doi: 10.1111/jnu.12580. Epub 2020 Jun 13.

    PubMed 32536026
  • He CC, Lin DM, Liu HZ, Wang FF, Guo XF, Zhang XB, Ai YQ, Meng LM. Nonpharmacological Interventions for Management of the Pain-Fatigue-Sleep Disturbance Symptom Cluster in Breast Cancer Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. J Pain Res. 2023 Aug 7;16:2713-2728. doi: 10.2147/JPR.S409798. eCollection 2023.

    PubMed 37577159
  • Fonseca das Neves J, Kornacka M, Serra E, Rollin N, Kosinski T, Marechal V, Jehel L, Rusinek S. The impact of rumination on fibromyalgia pain after physical activity: an experimental study. Sci Rep. 2023 Nov 22;13(1):20523. doi: 10.1038/s41598-023-47414-z.

    PubMed 37993555
  • Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P, Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol. 1990 Aug;17(8):1022-4.

    PubMed 2213777
  • Feldmann M, Hein HJ, Voderholzer U, Doerr R, Hoff T, Langs G, Herzog P, Kaiser T, Rief W, Riecke J, Brakemeier EL. Cognitive Change and Relaxation as Key Mechanisms of Treatment Outcome in Chronic Pain: Evidence From Routine Care. Front Psychiatry. 2021 Aug 3;12:617871. doi: 10.3389/fpsyt.2021.617871. eCollection 2021.

    PubMed 34413794
  • Dikmen HA, Terzioglu F. Effects of Reflexology and Progressive Muscle Relaxation on Pain, Fatigue, and Quality of Life during Chemotherapy in Gynecologic Cancer Patients. Pain Manag Nurs. 2019 Feb;20(1):47-53. doi: 10.1016/j.pmn.2018.03.001. Epub 2018 Dec 13.

    PubMed 29776873

Questions about this trial

What is this clinical trial studying?

A study testing Progressive Muscle Relaxation in people with End Stage Renal Disease (ESRD), run by Jordan University of Science and Technology at 1 site in Jordan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Arabic Pain Catastrophizing Scale (time frame: From enrollment to the end of treatment at 6 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07061028, which also lists 19 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in